指南与共识免疫规划卫生政策与健康促进

加强国家专家团队以支持东地中海国家人乳头瘤病毒疫苗引入:国际研讨会的经验与建议

Strengthening national teams of experts to support HPV vaccine introduction in Eastern Mediterranean countries: Lessons learnt and recommendations from an international workshop.
指南 / 共识 · Vaccine · 2019-11-23

东地中海区域人乳头瘤病毒(HPV)疫苗引入滞后,仅利比亚和阿联酋已引入。为支持各国决策,召开区域研讨会探讨引入计划现状、疾病负担数据缺口、社会文化与宗教挑战及国家免疫技术咨询小组(NITAG)作用,并提出推进决策过程的建议。

要点

  • 全球91国已引入HPV疫苗,东地中海区域仅利比亚和阿联酋引入。
  • 研讨会强调需疾病负担数据及HPV疫苗接种相关收益的证据。
  • 强调免疫、青少年健康、学校卫生、性与生殖健康及癌症控制规划间协作。

核心结论

  • 研讨会提高了东地中海国家对HPV疾病负担数据及HPV疫苗接种相关收益的认识。
  • 强调免疫、青少年健康、学校卫生、性与生殖健康及癌症控制等不同规划间协作的重要性。
  • 就如何推进HPV疫苗引入决策过程提出了建议。

研究设计与样本

  • 针对东地中海区域国家的国际研讨会,探讨HPV疫苗引入计划现状、信息缺口、社会文化与宗教挑战及NITAG作用。
  • 参会国反思各自HPV疫苗引入决策进程,讨论操作研究需求,并强调合作伙伴可能需要的技术与资金支持。

主要发现

  • 全球91个国家已引入HPV疫苗,东地中海区域目前仅利比亚和阿拉伯联合酋长国引入。
  • 研讨会识别了区域内HPV疾病负担信息缺口及对高质量HPV数据的需求。
  • 讨论了HPV疫苗引入面临的社会文化与宗教挑战。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Several countries have started to introduce the HPV vaccine into their national immunisation programme, with the majority of these countries being high or upper-middle income countries. Currently, 91 countries have introduced the HPV vaccine globally. One of the regions lagging behind in the introduction of the HPV vaccine is the Eastern Mediterranean Region, with currently only Libya and the United Arab Emirates having introduced the HPV vaccine. In order to support countries in the Eastern Mediterranean Region with their decision-making process for HPV vaccine introduction, a regional workshop was organised to explore the current status of HPV vaccine introduction plans in the Eastern Mediterranean countries, gaps in information about HPV disease burden in the region and the need for quality HPV data to make an informed decision to introduce the HPV vaccine, socio-cultural and religious challenges with HPV vaccine introduction, and the role of NITAGs in formulating recommendations for HPV vaccine introduction. Participating countries reflected on their respective status of decision making process about HPV vaccine introduction; they discussed any needs for operational research to support the decision-making process; and highlighed technical and financial support that might be required from partners to assist with HPV vaccine introduction. Recommendations were made on how to advance the decision-making process for HPV vaccine introduction. The workshop increased the awareness of the need of data on burden of disease and the associated benefits of HPV vaccination in Eastern Mediterranean countries. The importance of collaboration between different programmes including: immunisation, adolescent health, school health, sexual and reproductive health and cancer control programmes was clearly emphasized.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Dochez C, Al Awaidy S, Mohsni E, et al. Strengthening national teams of experts to support HPV vaccine introduction in Eastern Mediterranean countries: Lessons learnt and recommendations from an international workshop. Vaccine. 2019. PMID: 31771862. doi:10.1016/j.vaccine.2019.11.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。